| | | | | Aortic dissection
|
| | | | Natzi Sakalihasan, Christoph Nienaber
|
| 08.30
| | | Diagnostic algorithm for acute aortic dissection – imaging and biomarkers, Toru Suzuki |
| 08.40 | | | Therapeutic pathways in acute aortic dissection, Cesare Quarto |
| 08.50 | | | Individualized risk assessment in type B aortic dissection, Rachel Clough |
| 09.00 | | | Can we predict aortic size PRIOR to dissection? Yes! John Elefteriades |
| 09.10 | | | Computational modelling of type B aortic dissection: does it help manage patients? Barry Doyle |
| 09.20 | | | Initial experience in dissection of aorta in Nepal, Yadav Bhatta |
| 09.30 | | | Keynote lecture. TBA, Christoph Nienaber |
| 09.40 | | | Discussion |
| | | | |
| 10.00
| | | Coffee break
|
| | | | |
| | | | | Challenging cases of aortic dissection
|
| | | | Firas Mussa, Jean-Olivier Defraigne
|
| 10.30 | | | Aortic dissection – the great masquerader, James Yeh |
| 10.40 | | | Proximal aortic dissection – the role of the frozen elephant, Heinz Jakob |
| 10.50 | | | Proximal aortic dissection – the emerge of TEVAR, George Asimakopoulos |
| 11.00 | | | Staged repair of complex aortic dissection – safer or superfluous? Jullien Gaer |
| 11.10 | | | Retrograde aortic dissection after TEVAR: incidence, risk factors, precautions and treatment, Firas Mussa |
| 11.20 | | | Positive family history of aortic dissection dramatically increases dissection risk in family members, John Elefteriades |
| 11.30 | | | Clinical outcomes of TBADs in patients with connective tissue diseases (Marfans, Loeys-Dietz, etc.) are worse than in those without, Firas Mussa |
| 11.40 | | | Case presentation and discussion: Severe lower extremity malperfusion in a patient with acute type A dissection, what is the priority? Vincent Tchana-Sato |
| 11.50 | | | Type B aortic dissection in the patient with MYLK variants. What is the best solution: TEVAR or open repair? Vincent Tchana-Sato |
| 12.00 | | | Questions to experts and panel discussion
|
| | | | |
| 12.30 | | | Lunch break
|
| | | | |
| | | | | TEVAR for TAA
|
| | | | Eric Verhoeven, Hans-Henning Eckstein
|
| 13.30 | | | Open surgical conversion after TEVAR: incidence and treatment options, Domenico Baccellieri |
| 13.39 | | | Spinal cord ischemia in TAAA branched grafting, Eric Verhoeven |
| 13.48 | | | CSF drainage in TEVAR: anesthetic considerations, Gregory Hans |
| 13.57 | | | Neuromonitoring using motor and somatosensory evoked potentials in aortic surgery, John Elefteriades |
| 14.06 | | | Is there an increased risk to more complex fenestrated EVAR? Eric Verhoeven |
| 14.15 | | | Fenestrated and branched grafts: lessons after four years of the Windows trial, Jean-Pierre Becquemin |
| 14.24 | | | Consensus exercise on management of thoracic and thoracoabdominal aortic aneurysms in the United Kingdom, Srinivasa R. Vallabhaneni |
| 14.33 | | | Type B dissection: update on indications and results using a pragmatic policy, Fabien Koskas |
| 14.42 | | | Ask to experts and panel discussion
|
| | | | |
| | | | | Potpourri related with aortic diseases
|
| | | | Colin D. Bicknell, Apostolos Tassiopoulos |
| 15.00 | | | Radiation protection for patient and staff during routine EVAR and TEVAR procedures, Miltos Matsagas |
| 15.08 | | | Management aortic coarctation in 2016: surgery vs endovascular treatment, Colin D. Bicknell |
| 15.16 | | | Management of graft infection after EVAR-TEVAR. Can PET-CT predict the outcome of prosthetic graft infections? Natzi Sakalihasan |
| 15.32 | | | Extra anatomic bypass for congenital and acquired disorders of the thoracic aorta: indications, technique, results, Valeri Arakelyan |
| 15.47 | | | Keynote lecture. Medical errors during endovascular treatment for aortic diseases. How can we avoid them? Colin D. Bicknell |
| 15.57 | | | Discussion
|
| | | | Short communications from selected papers
|
| 16.20 | | | • Incidence, treatment and long-term clinical outcome in patients with aortic graft infections, Jennifer Pettersson |
| 16.25 | | | • Sex differences in outcomes after AAA repair in the United Kingdom, Matthew Bown |
| 16.30 | | | • Explantation of a fenestrated abdominal endograft with autologeous venous econstruction for infection, Catherine Terry |
| | | | |
| 16.40 | | | Coffee break
|
| | | | |
| | | | | Generalities on EVAR
|
| | | | Nicos Labropoulos, Isabelle Van Herzeele
|
| 17.10 | | | Impact of geometry and respiratory-induced deformation during snorkel/chimney and fenestrated endografts for complex abdominal aortic aneurysms, Ronald Dalman |
| 17.20 | | | Flow characteristics of Type II endoleaks. Does it matter? Nicos Labropoulos |
| 17.30 | | | Invisible endoleak after stent graft: a ghost or a myth? Eric Allaire |
| 17.40 | | | Apposition of the endograft post-EVAR. Improved technique to calculate and its importance to predict failure, Jean-Paul de Vries |
| 17.50 | | | Patients’ compliance with post-EVAR follow-up and its impact on the outcome, Athanasios Giannoukas |
| 18.00 | | | Early and long-term outcomes after open or endovascular repair for abdominal aortic aneurysms in high-risk patients, Domenico Palombo |
| 18.10 | | | Renal function is the main predictor of acute kidney injury after endovascular abdominal aortic aneurysm repair, Thanos Saratzis |
| 18.20 | | | Is there a role for use of endoanchors in EVAR or TEVAR procedures? Apostolos Tassiopoulos |
| 18.30 | | | Profile of secondary interventions after EVAR in current practice: how are they triggered and what are the implications for surveillance? Srinivasa R. Vallabhaneni |
| 18.50 | | | Case presentation, Isabelle Van Herzeele |
| 19.00 | | | Questions to experts and panel discussion
|
| | | | |
| 19.15 | | | End of the sessions
|
| | | | |